These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 12831586

  • 1. The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix.
    Tavaniotou A, Albano C, Van Steirteghem A, Devroey P.
    Reprod Biomed Online; 2003 Jun; 6(4):421-6. PubMed ID: 12831586
    [Abstract] [Full Text] [Related]

  • 2. [Revisiting the clomifene-gonadotropin protocol in IVF with the use of a GnRH antagonist].
    Emperaire JC, Parneix I, Perraguin-Jayot S.
    Gynecol Obstet Fertil; 2003 Nov; 31(11):927-31. PubMed ID: 14623556
    [Abstract] [Full Text] [Related]

  • 3. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF, Estes MA.
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [Abstract] [Full Text] [Related]

  • 4. Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?
    Engel JB, Ludwig M, Felberbaum R, Albano C, Devroey P, Diedrich K.
    Hum Reprod; 2002 Aug; 17(8):2022-6. PubMed ID: 12151431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
    Tavaniotou A, Albano C, Smitz J, Devroey P.
    Fertil Steril; 2002 Apr; 77(4):733-7. PubMed ID: 11937125
    [Abstract] [Full Text] [Related]

  • 7. Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.
    Lin YH, Seow KM, Hsieh BC, Huang LW, Chen HJ, Huang SC, Chen CY, Chen PH, Hwang JL, Tzeng CR.
    J Assist Reprod Genet; 2007 Aug; 24(8):331-6. PubMed ID: 17636445
    [Abstract] [Full Text] [Related]

  • 8. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
    Rongières-Bertrand C, Olivennes F, Righini C, Fanchin R, Taïeb J, Hamamah S, Bouchard P, Frydman R.
    Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
    [Abstract] [Full Text] [Related]

  • 9. Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles.
    Hwang JL, Huang LW, Hsieh BC, Tsai YL, Huang SC, Chen CY, Hsieh ML, Chen PH, Lin YH.
    Hum Reprod; 2003 Jan; 18(1):45-9. PubMed ID: 12525439
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.
    Lee TH, Lin YH, Seow KM, Hwang JL, Tzeng CR, Yang YS.
    Fertil Steril; 2008 Jul; 90(1):113-20. PubMed ID: 18054932
    [Abstract] [Full Text] [Related]

  • 11. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.
    Lin YH, Hwang JL, Seow KM, Huang LW, Hsieh BC, Tzeng CR.
    Gynecol Endocrinol; 2006 Jun; 22(6):297-302. PubMed ID: 16785154
    [Abstract] [Full Text] [Related]

  • 12. The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol.
    Mansour R, Aboulghar M, Serour GI, Al-Inany HG, Fahmy I, Amin Y.
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):48-52. PubMed ID: 12580839
    [Abstract] [Full Text] [Related]

  • 13. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
    Ochin H, Ma X, Wang L, Li X, Song J, Meng Y, Shen J, Cui YG, Liu J.
    J Ovarian Res; 2018 May 04; 11(1):37. PubMed ID: 29728130
    [Abstract] [Full Text] [Related]

  • 14. Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
    Nyachieo A, Spiessens C, Chai DC, Mwenda JM, D'Hooghe TM.
    Fertil Steril; 2009 Feb 04; 91(2):602-10. PubMed ID: 18328482
    [Abstract] [Full Text] [Related]

  • 15. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.
    Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T, Krebs D, Klingmüller D.
    Hum Reprod; 1994 May 04; 9(5):788-91. PubMed ID: 7929723
    [Abstract] [Full Text] [Related]

  • 16. Impact of estradiol patterns in clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol.
    Lin YH, Seow KM, Chen HJ, Huang LW, Hwang JL, Tzeng CR.
    Gynecol Endocrinol; 2007 Jan 04; 23(1):45-9. PubMed ID: 17484512
    [Abstract] [Full Text] [Related]

  • 17. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
    Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L, Nicollet B, Zorn JR, Bouchard P, Frydman R.
    Fertil Steril; 2000 Feb 04; 73(2):314-20. PubMed ID: 10685535
    [Abstract] [Full Text] [Related]

  • 18. Effect of cetrorelix dose on premature LH surge during ovarian stimulation.
    Lin YH, Seow KM, Chen HJ, Hsieh BC, Huang LW, Tzeng CR, Hwang JL.
    Reprod Biomed Online; 2008 Jun 04; 16(6):772-7. PubMed ID: 18549685
    [Abstract] [Full Text] [Related]

  • 19. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
    Albano C, Felberbaum RE, Smitz J, Riethmüller-Winzen H, Engel J, Diedrich K, Devroey P.
    Hum Reprod; 2000 Mar 04; 15(3):526-31. PubMed ID: 10686191
    [Abstract] [Full Text] [Related]

  • 20. Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?
    Craft I, Gorgy A, Hill J, Menon D, Podsiadly B.
    Hum Reprod; 1999 Dec 04; 14(12):2959-62. PubMed ID: 10601078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.